The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Validation of the RSClin risk calculator using the National Cancer Database (NCDB).
 
Frederick Howard
No Relationships to Disclose
 
Alexander T. Pearson
Stock and Other Ownership Interests - Inovalon (I)
Consulting or Advisory Role - Prelude Therapeutics
 
Rita Nanda
Consulting or Advisory Role - Aduro Biotech; Athenex; Daiichi Sankyo; Genentech/Roche; Immunomedics; ION Pharma; Macrogenics; Merck; Pfizer; Seagen
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Celgene (Inst); Corcept Therapeutics (Inst); Genentech/Roche (Inst); Immunomedics (Inst); Merck (Inst); Odonate Therapeutics (Inst); Pfizer (Inst); Seagen (Inst)
Other Relationship - G1 Therapeutics
 
Olufunmilayo I. Olopade
Employment - CancerIQ (I)
Leadership - CancerIQ
Stock and Other Ownership Interests - 54gene; CancerIQ; Tempus
Research Funding - Novartis (Inst); Roche/Genentech (Inst)
Other Relationship - Color Genomics; Roche/Genentech; Tempus
(OPTIONAL) Uncompensated Relationships - Healthy Life for All Foundation
 
Dezheng Huo
No Relationships to Disclose